基因工程乙肝疫苗,目前已是计划免疫用生物制剂,我院自1997年至今,共注射了千余人次,其中1例因皮下注射乙肝疫苗导致过敏性休克,现将抢救、护理体会报告如下。1　病例介绍患者男,12岁,微胖,平时身体健康,既往无食物、药物过敏史。于1997年7月29日第1次三角肌注射乙肝疫苗5μｇ/ Hepatitis B vaccine genetically engineered, is now planned immunosuppressive agents, our hospital since 1997, a total of more than a thousand people were injected, of which 1 case due to subcutaneous injection of hepatitis B vaccine lead to anaphylactic shock, now rescue, nursing experience is reported as follows. 1 case description Male patient, 12 years old, slightly fat, usually healthy, past no food, drug allergy history. In July 29, 1997 the first deltoid injections of hepatitis B vaccine 5μg /